Drugs / phenylacetate
last change Sep 2004 re-read 3 minutes ago

phenylacetate

Developed for
central nervous system neoplasm
Investigated by
National Cancer Institute (NCI) · Texas Children's Cancer Center

Trials 1

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00003241 May 1998 → Sep 2004 central nervous system neoplasm Texas Children's Cancer Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as phenylacetate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003241 ↗
Route Intravenous “continuous intravenous infusion” NCT00003241 ↗